Guardant Health, Inc. (GH)
93.84
+2.69
(+2.95%)
USD |
NASDAQ |
Apr 02, 16:00
93.84
0.00 (0.00%)
After-Hours: 19:09
Guardant Health Research and Development Expense (TTM) : 364.19M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Quest Diagnostics, Inc. | -- |
| Illumina, Inc. | 950.00M |
| Natera, Inc. | 624.11M |
| Labcorp Holdings, Inc. | -- |
| GeneDx Holdings Corp. | 70.69M |